Vincent JL - Search Results

1

Abandon the mouse research ship? Not just yet!

Osuchowski MF, Remick DG, Lederer JA, Lang CH, Aasen AO, Aibiki M, Azevedo LC, Bahrami S, Boros M, Cooney R, Cuzzocrea S, Jiang Y, Junger WG, Hirasawa H, Hotchkiss RS, Li XA, Radermacher P, Redl H, Salomao R, Soebandrio A, Thiemermann C, Vincent JL, Ward P, Yao YM, Yu HP, Zingarelli B, Chaudry IH. Osuchowski MF, et al. Among authors: vincent jl. Shock. 2014 Jun;41(6):463-75. doi: 10.1097/SHK.0000000000000153. Shock. 2014. PMID: 24569509 Free PMC article.

2

Rapid alterations in transferrin sialylation during sepsis.

Piagnerelli M, Boudjeltia KZ, Nuyens V, De Backer D, Su F, Wang Z, Vincent JL, Vanhaeverbeek M. Piagnerelli M, et al. Among authors: vincent jl. Shock. 2005 Jul;24(1):48-52. doi: 10.1097/01.shk.0000168524.20588.67. Shock. 2005. PMID: 15988320

3

Modifications in erythrocyte membrane protein content are not responsible for the alterations in rheology seen in sepsis.

Piagnerelli M, Cotton F, Van Nuffelen M, Vincent JL, Gulbis B. Piagnerelli M, et al. Among authors: vincent jl. Shock. 2012 Jan;37(1):17-21. doi: 10.1097/SHK.0b013e318237d55a. Shock. 2012. PMID: 21941224 Clinical Trial.

4

The future of observational research and randomized controlled trials in red blood cell transfusion medicine.

Vincent JL, Sakr Y, Lelubre C. Vincent JL, et al. Shock. 2014 May;41 Suppl 1:98-101. doi: 10.1097/SHK.0000000000000090. Shock. 2014. PMID: 24662781

5

Nivolumab plus interferon-γ in the treatment of intractable mucormycosis.

Grimaldi D, Pradier O, Hotchkiss RS, Vincent JL. Grimaldi D, et al. Among authors: vincent jl. Lancet Infect Dis. 2017 Jan;17(1):18. doi: 10.1016/S1473-3099(16)30541-2. Lancet Infect Dis. 2017. PMID: 27998559 No abstract available.

6

Sepsis and septic shock.

Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Hotchkiss RS, et al. Among authors: vincent jl. Nat Rev Dis Primers. 2016 Jun 30;2:16045. doi: 10.1038/nrdp.2016.45. Nat Rev Dis Primers. 2016. PMID: 28117397 Free PMC article. Review.

7

Monocyte CD40 expression in severe sepsis.

Sugimoto K, Galle C, Preiser JC, Creteur J, Vincent JL, Pradier O. Sugimoto K, et al. Among authors: vincent jl. Shock. 2003 Jan;19(1):24-7. doi: 10.1097/00024382-200301000-00005. Shock. 2003. PMID: 12558139

8

Impairment of beta-adrenergic signaling in healthy peripheral blood mononuclear cells exposed to serum from patients with septic shock: involvement of the inhibitory pathway of adenylyl cyclase stimulation.

Bernardin G, Kisoka RL, Delporte C, Robberecht P, Vincent JL. Bernardin G, et al. Among authors: vincent jl. Shock. 2003 Feb;19(2):108-12. doi: 10.1097/00024382-200302000-00003. Shock. 2003. PMID: 12578116

9

Hemodynamic effects of glibenclamide during endotoxemia: contrasting findings in vitro versus in vivo.

Preiser JC, Zhang H, Debelle F, Fesler P, Kafi SA, Naeije R, Vincent JL. Preiser JC, et al. Among authors: vincent jl. Shock. 2003 Mar;19(3):223-8. doi: 10.1097/00024382-200303000-00005. Shock. 2003. PMID: 12630521

10

Differential effects of a selective inhibitor of soluble guanylyl cyclase on global and regional hemodynamics during canine endotoxic shock.

Preiser JC, Sun Q, Hadj-Sadok D, Vincent JL. Preiser JC, et al. Among authors: vincent jl. Shock. 2003 Nov;20(5):465-8. doi: 10.1097/01.shk.0000092267.01859.e9. Shock. 2003. PMID: 14560112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,457 results

Search Page